Holen Sie sich die Stockscreener-App
406.69
4.20%
-17.84
Handel nachbörslich:
406.69
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ELV?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$424.53
Offen:
$421.66
24-Stunden-Volumen:
2.29M
Relative Volume:
1.38
Marktkapitalisierung:
$99.88B
Einnahmen:
$176.81B
Nettoeinkommen (Verlust:
$5.98B
KGV:
15.88
EPS:
25.61
Netto-Cashflow:
$4.55B
1W Leistung:
-7.82%
1M Leistung:
-4.80%
6M Leistung:
-3.69%
1J Leistung:
-23.47%
1-Tages-Spanne:
$402.21
$422.45
1-Wochen-Bereich:
$390.00
$441.47
52-Wochen-Spanne:
$362.21
$567.26
Elevance Health Inc Stock (ELV) Company Profile
Firmenname
Elevance Health Inc
Sektor
Branche
Telefon
(800) 331-1476
Adresse
220 VIRGINIA AVENUE, INDIANAPOLIS
Vergleichen Sie ELV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
406.69 | 99.88B | 176.81B | 5.98B | 4.55B | 25.61 |
|
UNH
Unitedhealth Group Inc
|
425.33 | 548.34B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
324.77 | 89.25B | 244.38B | 3.43B | 8.96B | 12.24 |
|
CVS
Cvs Health Corp
|
65.17 | 87.36B | 372.81B | 4.61B | 6.33B | 3.66 |
|
HUM
Humana Inc
|
245.91 | 34.38B | 117.76B | 1.21B | 2.39B | 9.95 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Hochstufung | Argus | Hold → Buy |
| 2025-01-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Herabstufung | Argus | Buy → Hold |
| 2024-07-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
Alle ansehen
Elevance Health Inc Aktie (ELV) Neueste Nachrichten
Why Elevance Health (ELV) Is Among the Best Telehealth Stocks to Buy Now - Insider Monkey
Elevance Health (ELV) Set for Q1 Earnings Release - GuruFocus
NovaSight Ltd. Achieves Major Milestone: Insurance Coverage Secured for Eye-Tracking-Based Digital Amblyopia Therapy - Fresno Bee
Elevance Health Earnings: What To Look For From ELV - Yahoo Finance
Elevance Health preannounced Q1 earnings beat ‘quite positive,’ says Baird - Yahoo Finance
Will a Strong MA Business Aid Elevance Health's Q1 Earnings? - MSN
Elevance Health's Preliminary Q1 Earnings Help Ease Market Concerns, Truist Says - marketscreener.com
Elevance Health Expects Adjusted Q1 Net Income Of $11.97 Per Diluted Share - marketscreener.com
Elevance: Delivers Strong Preliminary Q1 Earnings and 2025 Outlook, Shares Undervalued - Morningstar
UnitedHealth Casts Gloom Over Insurers After Shock Forecast Cut - Bloomberg.com
MU Health 'out of network' for Elevance Health/Anthem patients after insurer fails to reach agreement - Read Lion
Elevance Health Expects Q1 Earnings Above Estimates, Retains Full-Year Guidance: But Retail’s Pessimistic - Investing.com India
Elevance Health (ELV) Surpasses Q1 Earnings Projections, Maintains Full-Year Outlook - GuruFocus
Elevance Maintains Profit Guidance After UnitedHealth Cut - Bloomberg.com
Elevance Health's Preliminary Q1 Adjusted Net Income Rises - marketscreener.com
CVS, Humana and Elevance Shares Are Trading Lower Thursday: What's Going On? - Benzinga
Elevance Health projects steady Q1 results, confirms 2025 outlook - Investing.com
Elevance Health stock in focus after Q1 outlook (ELV:NYSE) - Seeking Alpha
Elevance Health Projects Q1 2025 Earnings Expectations - TipRanks
Elevance Health projects steady Q1 results, confirms 2025 outlook By Investing.com - Investing.com South Africa
Elevance maintains profit forecast after rival UnitedHealth's outlook cut - Reuters
Elevance Health (ELV) to Announce Q1 2025 Earnings on April 22 | ELV Stock News - GuruFocus
Elevance Health (ELV) to Announce Q1 2025 Financial Results on April 22 | ELV Stock News - GuruFocus
Health insurer Elevance sees first-quarter profit above estimates - marketscreener.com
Ahead of Elevance Health (ELV) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance
Anthem Strikes Deal To End Mental Health Class Action - Law360
Baird Downgrades Elevance Health (BIT:1ANTM) - Nasdaq
Elevance Health (NYSE:ELV) Faces Shareholder Proposal on Diversity and Inclusion Reporting - Yahoo Finance
Morgan Stanley Adjusts Elevance Health Price Target to $428 From $405, Maintains Equal Weight Rating - MarketScreener
Elevance Health (NYSE:ELV) stock performs better than its underlying earnings growth over last five years - Yahoo Finance
Elevance Health (ELV) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
How Do Investors Really Feel About Elevance Health? - Benzinga
Implied Volatility Surging for Elevance Health (ELV) Stock Options - Nasdaq
Morgan Stanley Adjusts Price Target for Elevance Health (ELV) to $428 | ELV Stock News - GuruFocus
Elevance Health (ELV) Downgraded by Baird Amid Policy Uncertaint - GuruFocus
Elevance Health: A Hidden Gem Amongst Healthcare Turbulence - Seeking Alpha
5 of the Safest Stocks Billionaire Money Managers Bought Ahead of Wall Street's Historic Volatility - The Motley Fool
Truist Increases Price Target for Elevance Health (ELV) Ahead of Q1 Results | ELV Stock News - GuruFocus
Elevance Health, Inc. (ELV): Among the Best Medical Stocks to Buy According to Billionaires - Insider Monkey
Truist Securities Raises Price Target on Elevance Health to $510 From $480, Keeps Buy Rating - MarketScreener
Elevance Health, Inc.'s (NYSE:ELV) Stock Is Going Strong: Is the Market Following Fundamentals? - Yahoo
Elevance Beats Teacher's Bias Suit Over Weight Loss Drugs - Law360
Guggenheim Initiates Coverage of Elevance Health (BMV:ELV) with Buy Recommendation - Nasdaq
Guggenheim Initiates Coverage of Elevance Health (WBAG:ELV) with Buy Recommendation - Nasdaq
Guggenheim Initiates Coverage of Elevance Health (BIT:1ANTM) with Buy Recommendation - Nasdaq
Elevance Beats Bias Claim Over Plan's Weight Loss Drug Exclusion - Bloomberg Law News
Elevance Health (ELV) is Rebounding From Sell Off - Insider Monkey
Guggenheim Initiates Coverage of Elevance Health (ELV) with Buy Recommendation - Nasdaq
Jared Moskowitz trades in Broadcom and Elevance Health stocks, buys into NVIDIA, SPDR Gold Trust, and TJX Companies - Investing.com India
5 Analysts Assess Elevance Health: What You Need To Know - Benzinga
Elevance Health Women's Fort Myers Tip-Off comes to Scripps Sports, ION in multiyear agreement - Yahoo Finance
Finanzdaten der Elevance Health Inc-Aktie (ELV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):